Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. (Q51320250)

3 April 2018

title

Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. (English)

1 reference

3 April 2018

Martin H Maurer

3

0 references

Bernd Hamm

8

object named as

Bernd Hamm

1 reference

3 April 2018

Vera Froeling

1

1 reference

3 April 2018

Florian Elgeti

2

1 reference

3 April 2018

Christian Scheurig-Muenkler

4

1 reference

3 April 2018

Alexander Beck

5

1 reference

3 April 2018

Thomas J Kroencke

6

1 reference

3 April 2018

Ulrich-Frank Pape

7

1 reference

3 April 2018

Winfried Brenner

9

1 reference

3 April 2018

Nils F Schreiter

10

1 reference

3 April 2018

publication date

4 August 2012

1 reference

3 April 2018

Annals of Nuclear Medicine

published in

1 reference

3 April 2018

volume

26

1 reference

3 April 2018

issue

9

1 reference

3 April 2018

page(s)

738-743

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s12149-012-0634-z

exact match

0 references

cites work

Multiple endocrine neoplasia type 1: new clinical and basic findings

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Multiple endocrine neoplasia type 2A: a 25-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Update multiple endocrine neoplasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27Kip1 and p18INK4C) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Functional imaging of endocrine tumors: role of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Radiolabelling DOTA-peptides with 68Ga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

The radionuclide molecular imaging and therapy of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0634-Z

10.1007/S12149-012-0634-Z

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018